1Poste G, Fidler IJ. Thepathogenesis of cancer metastasis [J]. Nature, 1980,283(5742): 139~146.
2Hellmann K, Burrage K. Control of malignant metastses by ICRF 159 [J]. Nature,1969,224(5216):273~275.
3Neri A, welch D, Kawaguchi T, et al. Development and biologic propertes ofmalignant cell sublines and clones of spontaneously metastasizing rat mammaryadenocarcinoma [J] .J Nail Cancer Inst, 1982,68(3) :507~517.
4Kamishohara M, Kawai H, Sakai T, et al. Inhibitory effect of a spicamycinderivative KRN5500 on the growth of hepatic matastasis of human colon cancer-producingtissue polypeptide antigen [J]. Cancer Chemther Pharmacol,1996,38(6) :495~498.
5Kuruppu D, Christophi C, Bertrain JF, et al. Characterization of an animal model ofhepatic metastasis [J] .J Gastroentero Hepatol,1996,11(1):26~32.
6Tsuruo T,Naganume K,Lida H,et al. Lymphonode metastasisis and effects of 1β-d-arabinofuranosylcytosine, 5-fluorouracil and their lipophilic derivatives in an experimental model systemusing P388 leukemia [J]. Cancer Res, 1980, 40(12) :4758~4763.
7Nicolson GL. Metastatic tumor cell attachment and invasion assay u tilizingvascular endothelial cell monolayers [J].J Histochem Cytochem, 1982,30(1):214~220.
8Alby L, Auerbach R. Differential adhesion of tumor cells to capillary endothelialcells in vitro [J] .Proc Natl Acad Sci USA,1984,81(18):5739~5743.
9De-Vries TJ,Wan-Wuijen GNP,Ruiter DJ.The plasminogen activation system in trmorinvasion and metastasis. Pathol Res Prac, 1996,192(7) :718~733.